GRAP
GRB2-related adapter protein
Also known as: GRAP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13588
- Gene
- GRAP
- Ensembl
- ENSG00000154016
- Chromosome
- 17
- Canonical length
- 217 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Centrosome
OverviewNCBI Gene
This gene encodes a member of the GRB2/Sem5/Drk family and functions as a cytoplasmic signaling protein which contains an SH2 domain flanked by two SH3 domains. The SH2 domain interacts with ligand-activated receptors for stem cell factor and erythropoietin, and facilitates the formation of a stable complex with the BCR-ABL oncoprotein. This protein also associates with the Ras guanine nucleotide exchange factor SOS1 (son of sevenless homolog 1) through its N-terminal SH3 domain. In general, it couples signals from receptor and cytoplasmic tyrosine kinases to the Ras signaling pathway. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
217 residues, UniProt reviewed canonical sequence.
>Q13588|GRAP
1 MESVALYSFQ ATESDELAFN KGDTLKILNM EDDQNWYKAE LRGVEGFIPK NYIRVKPHPW
61 YSGRISRQLA EEILMKRNHL GAFLIRESES SPGEFSVSVN YGDQVQHFKV LREASGKYFL
121 WEEKFNSLNE LVDFYRTTTI AKKRQIFLRD EEPLLKSPGA CFAQAQFDFS AQDPSQLSFR
181 RGDIIEVLER PDPHWWRGRS CGRVGFFPRS YVQPVHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRAP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 50 nTPM
Expression across tissuesHPA
Tissue
- spleen: 50 nTPM
- lymph node: 35 nTPM
- thymus: 30 nTPM
- tonsil: 29 nTPM
- small intestine: 20 nTPM
- appendix: 13 nTPM
Single-cell type
- lymphatic endothelial cells: 49 nCPM
- b-cells: 26 nCPM
- hofbauer cells: 18 nCPM
- vascular endothelial cells: 13 nCPM
- hematopoietic stem cells: 8.2 nCPM
- thymocytes: 7.6 nCPM
Immune cell
- naive CD4 T-cell: 134 nTPM
- memory B-cell: 100 nTPM
- naive B-cell: 83 nTPM
- memory CD4 T-cell: 68 nTPM
- naive CD8 T-cell: 67 nTPM
- T-reg: 63 nTPM
Brain region
- thalamus: 5.3 nTPM
- pons: 4.8 nTPM
- amygdala: 4.6 nTPM
- medulla oblongata: 4.6 nTPM
- midbrain: 4.2 nTPM
- spinal cord: 4.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRAP.
Disease | AllUniProt
Conditions GRAP is implicated in, by any mechanism.
- Deafness, autosomal recessive, 114 (DFNB114) MIM:618456
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 22 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hearing loss, autosomal recessive 114
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 1.14
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- Ras protein signal transduction
- regulation of MAPK cascade
- sensory perception of sound
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRAP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRAP as an antibody target. Whether an autoantibody or antibody against GRAP could matter depends on whether native GRAP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRAP is annotated at the cell surface, where native GRAP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRAP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...